<img src="https://secure.24-astute.com/796183.png" style="display:none;">

Our People

 

Dr. Torsten Neuefeind

CEO
Torsten founded Proteros based on the belief that structural biology services would become a key market requirement in the future of industrial Drug Discovery.
 
Torsten set up the company based on a McKinsey & Co awarded business plan and the experience of his PhD thesis in the lab of Nobel prize winner Prof. R. Huber at the Max Planck Institute of Biochemistry, Munich as well as at Bayer AG. He set up the company structure, including high performance teams, a supervisory board and involvement of Prof. Huber as a co-founder and scientific advisor. He continues to manage the financing of the growth of the company in all stages and developed the business in Europe, US and Japan and made Proteros a renowned market leader in its segment, awarded as one of Bavaria’s best innovative growth companies. 
Torsten_bw
 
Under Torsten’s guidance, the business has grown to serve most of the Top 20 Big Pharma Companies, numerous midsize Pharma and more than 200 Biotech and virtual Biotech companies with a strong presence in the US, including a partnership with a US Venture Capital firm, resulting in a successful exit of a jointly funded company, worth several hundred million ‘Bio-Dollars’. Proteros today is a premier provider of structure accelerated early Drug Discovery services, with a clear focus on scientific excellence and the most challenging drug targets and is a highly regarded brand in the community.

Torsten holds a degree in chemistry and a PhD with summa cum laude from the Technical University Munich including business courses e.g. from INSEAD. He serves on various Boards and is located in Munich.
 

 

 

RYAN BRADY

CHIEF BUSINESS OFFICER

Ryan Brady leads Proteros’ global commercial strategy — spanning business development, strategic partnerships, client engagement, and marketing — as we continue our mission to support our clients to reach the right results and accelerate their overall research timelines, helping them to open the door to lead optimization and clinical programs. Ryan brings over 20 years of experience with a proven track record in the key areas of business development and strategic partnerships in our industry. Prior to joining Proteros, he held the position as Head of Global Discovery Business Development at Evotec Throughout his career, Ryan has consistently demonstrated a passion for connecting cutting-edge science with impactful partnerships with customers — building bridges between innovation and execution to help clients advance tomorrow’s medicines faster and smarter.

LinkedIn

Ryan-Brady-1

 

Prof. Eric P. Pâques 

board member

Eric P. Pâques is Non-Executive Chairman of the Supervisory Board of Proteros Biostructures GmbH (Munich, Germany) since 2014, chairman of the Board of Directors of Novadip Biosciences (Belgium) and Board member of Epics Therapeutics (Belgium) and of PL Bioscience (Germany) as well as of several academic and charity organizations. He was Independent Director of INC Research Inc., later Syneos Health, (USA), and Vice-Chairman of the Supervisory Board of the Grünenthal Group (Germany). He served more than 35 years in management positions in the pharmaceutical industry, thereof 20 years as General Manager / CEO of the Grünenthal Group. He is professor at the RWTH-Aachen University (Germany) and holds a Master degree and a PhD in Chemistry (University of Louvain, Belgium).

LinkedIn

 

 

Eric-P-Pâques-1

Lara Kurth 

Head of Finance

Lara leads Proteros´ Finance function and is responsible for shaping and overseeing the Financial Strategy, Accounting, Controlling and Tax functions at Proteros. Lara brings a broad range of experience within finance. Before joining Proteros in January 2024, she acted as Vice President at a global Investment Bank, advising mid-sized companies on Mergers & Acquisitions transactions in the Healthcare sector. Prior to that, she was part of KPMG’s M&A advisory team.

Lara holds a Master degree in Accounting and Finance from the University St. Gallen, Switzerland and a B.A. in Business and Economics from the University of Basel, Switzerland.

LinkedIn

 

Lara_266-jpg